Oral Thin Film Drugs Market Size to USD 4,068.7 Mn by 2023 | Massive Growth with 10.50% CAGR by Worldwide Top Players
Jan 15, 2019
Exclusive Overview by MarketResearchFuture.com of Global Oral Thin Film Drugs Market Research Report 2019 to 2023, with respect to region specific market growth and competitive analysis on the basis of major players present in the market.
Pune, India - January 15, 2019 /MarketersMedia/ —
Oral Thin Film Drugs Market – Overview
Global Oral Thin Film Drugs Market is expected to touch a valuation of USD 4,068.7 million by 2023, according to Market Research Future (MRFR). High demand for oral thin film (OTF) drugs by pediatric and geriatric populace globally is its major market driver. The fast dissolving medicines act as a better alternative to capsules, syrups, and tablets. These drugs are beneficial for patients on the go or patients with swallowing problems.
Drugs which cannot be offered via the oral route and its limitations on dosage can hamper the market. But opportunities in developing regions can bolster the oral thin film drugs market demand during the forecast period.
The sharp rise noticed in the numbers of the elderly populace are likely to evoke the demand for OTF drugs from 2018 to 2023 (forecast period). According to World Population Prospects by the United Nations, the geriatric population had touched 962 million in 2017. In addition, their weak immunity levels make them susceptible to various chronic diseases. This factor can have a direct effect on market demand.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6547
Oral Thin Film Drugs Market - Regional Analysis:
The oral thin film drugs market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas accounted for the lion’s share of the market in 2017 owing to the presence of well-known players in the healthcare sector, increased healthcare expenditure of nations such as the U.S., and sophisticated healthcare expenditure. According to the World Health Organization (WHO), the population of North America can expand at 42% from 2000 to 2050 and this can have a noticeable impact on the market. The mushrooming of retail pharmacies to cater to demands of patients can propel the Americas market to grow at a 10.72% CAGR during the forecast period.
The Europe oral thin film drugs market can experience a 9.44% CAGR over the forecast period owing to supportive government fiats and healthcare funds. Strong economies of France, Germany, and the U.K. can contribute to market revenue till 2023.
The APAC region is touted to experience a robust growth rate owing to developing economies, changing healthcare sector, and increasing geriatric population. It can touch a valuation of USD 543.3 million by 2023. This can be credited to fast-moving economies of India, Japan, and China.
The MEA region may experience a sluggish growth rate owing to slow economic growth of countries in Africa. But well-developed countries such as Kuwait, Qatar, and the United Arab Emirates (UAE) and their increased healthcare budgets can drive the regional market growth over the forecast period.
Oral Thin Film Drugs Market - Segmentation:
The oral thin film drugs market can be segmented by product, disease indication, and distribution channel.
By form, the market is segmented into fast dissolving buccal film and sublingual. The fast dissolving film segment accounted for 58% share in the oral thin film drugs market in 2017. This can be credited to the potential of OTF drugs in dissolving rapidly and its efficacy and safety. It can enjoy good dividends at a 11.31% CAGR over the forecast period. On the other hand, the sublingual segment can enjoy a 9.34% CAGR to touch a valuation of USD 1,622.3 million by 2023.
By disease indication, the market is segmented into migraine, schizophrenia, opioid dependence, and nausea and vomiting, and others. Among these, the schizophrenia segment accounted for 36% market share in 2017. It can generate market demand at a 10.34% CAGR over the forecast period. On the flip side, the migraine segment can grow at a robust pace owing to high prevalence of migraine attacks.
Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/oral-thin-film-drugs-market-6547
By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online drug stores, and others. The retail pharmacies segment accounted for 46.9% market share in 2017. This can be attributed to the increasing patient population and their respective treatment at hospitals. In addition, the low cost of drugs at these pharmacies compared to hospital pharmacies can thrust the segment valuation to USD 1,930.9 million by 2023. But the online drug stores segment is expected to generate returns at an 11.66% CAGR over the forecast period.
Top Players:
Prominent players operating in the oral thin film drugs market include Novartis AG (Switzerland), Indivior Plc (U.S.), LTS Lohmann Therapie-Systeme AG (Germany), GlaxoSmithKline Plc (U.K.), CURE Pharmaceutical (U.S.), Pfizer Inc. (U.S.), and Johnson & Johnson Services, Inc. (U.S.).
Some Points from TOC of Oral Thin Film Drugs Market Research Report – Forecast to 2023:
1 Report Prologue
2 Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Oral Thin Film Drugs Market by Product
7 Global Oral Thin Film Drugs Market by Disease Indication
TOC CONTINUED….
Check Discount at https://www.marketresearchfuture.com/check-discount/6547
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/oral-thin-film-drugs-market-6547
Source: MarketersMedia
Release ID: 470819
More News
Weak Links Start to Show in A.I. Borrowing
Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there is broader trouble with the data center build-out.
Call for more food funding due to high living cost
Deputy Louise Doublet does not think the cost of living was considered in the ending of a trial.
Charity reflects on changing needs over 25 years
Help a Guernsey Child says it has provided in excess of £1.2m worth of essential support.
Nightclubs are disappearing - and it's affecting young people
One young person said with no nightlife in their town they cannot "let loose and mess around".
Netflix Hurries to Rewrite Its Narrative With Layoffs and a Sudden Firing
Despite strong revenues and profits, the streaming service cut 1,000 jobs and jettisoned its chief content officer. Drops in the stock price and viewer engagement are to blame.
Why Bad News in the Bond Market May Be Good News for Investors
In the contrarian logic of investing, rising interest rates have made bonds much more attractive, our columnist says.
U.S. Budget Deficit Nears $2 Trillion, a Reality Check for Trump’s Cost Cutting
Higher interest rates are inflating borrowing costs as the Trump administration spends on the Iran war and tariff refunds.
Indonesian Stocks Plunge as MSCI Threatens to Drop Market from Indexes
The potential downgrade by MSCI, an influential index provider, adds to a deepening crisis of investor confidence in the economic policies of President Prabowo Subianto.
Warsh Vows to Tame Inflation as A.I. Delivers ‘Shock’ to Economy
The Federal Reserve chairman stuck to his pledge to avoid providing guidance about the path forward for interest rates, but did nothing to convey an urgency to raise them later this month.
A new railway corridor: How Nanning links Chinese and ASEAN markets
A new railway corridor: How Nanning links Chinese and ASEAN markets
Watch: Did Tesla really just unveil a flying car?
Tesla CEO Elon Musk showcased the vehicle at a facility owned by his SpaceX company, which helped develop the model.
China and Europe are building new connections in aerospace
China and Europe are building new connections in aerospace – from skies to stars. On the one hand, their deep industrial partnership is scaling global civil aviation to new heights. On the other hand, scientific collaboration is opening new possibilities for space exploration and deepening our understanding of the Sun-Earth system.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.